Healthcare -
Biotechnology - NASDAQ - US
$ 5.25
8.25 %
$ 111 M
Market Cap
-0.96
P/E
ENTA - OPERATING EXPENSES
Operating Expenses ENTA - Enanta Pharmaceuticals, Inc.
189 M
LAST VALUE
-5.05%
2 YEAR CAGR
2.36%
5 YEAR CAGR
20.74%
10 YEAR CAGR